Reforms to the Personal Independent Payment sat at the heart of a major Labour rebellion last year over welfare. What is the future of the benefit?

The day I finish reading The Next Fix: The Winners and Losers Inside the Future of Drugs, by Professor Kojo ...

As a major global review is published this week, it is no longer a question of whether cannabis should be legalized, but how, and what comes next.

Following a landmark Executive Order accelerating psychedelic access in the U.S. new polling shows support for psilocybin-assisted therapy extends across British politics

Science is at odds with the ‘medical use’ of cannabis: does it help with mental health, or is there something else at play?

Women are reshaping medical cannabis as gaps in women’s health persist, pushing for fairer access and smarter products.

As Zack Polanski pledges to legalise drugs, Labour and Reform are on the attack. We dive into this controversial policy – what does the evidence say?

Nearly one in four Americans now believe that the use of psilocybin or “magic” mushrooms should be legal as 10 million report microdosing psychedelics in the past year

Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase 3 trial in depression.

“The war on drugs has failed,” Zack Polanski told reporters in October 2025. The new leader of the Green Party ...

The European Commission’s draft EU Drug Strategy has triggered a backlash, warning that the framework could complicate Europe’s emerging legal cannabis markets.

President Donald Trump has signed an executive order to move cannabis from Schedule I to Schedule III under the Controlled Substances Act

The government has approved a decree setting out the conditions for the use of psilocybin in treatment-resistant depression and other serious mental health disorders.

Last week, German biotech startup Vertanical announced that its new cannabis-derived drug worked better than opioids in clinical trials for chronic lower-back pain.

After almost three decades of psychopharmacological research—and having treated thousands of psychiatric patients with psychotropic drugs like antidepressants and antipsychotics—Dr. ...

Germany has given the green light for two medical facilities to offer psilocybin to adults with treatment-resistant depression.

Brain health has been an obscure science – until now.

The government’s 10-year plan for the NHS promises bold transformation, with a move towards digital innovation, and more focus on prevention over treatment, but does it go far enough to address the UK’s gender health gap? Health Secretary Wes

The versatile cannabis plant could, some scientists think, one day be useful for lunar and Martian colonists. For now, researchers will subject its seeds to radiation in orbit and see what happens.

Decriminalization has happened, but cannabis clubs are hard to roll out and the new government could be an obstacle to the legal-sales phase.